Enteric coated capsules are a specialized form of drug delivery system that have gained significant attention in the pharmaceutical industry. As a leading supplier of enteric coated capsules, I have witnessed firsthand the impact these capsules can have on drug absorption. In this blog post, I will delve into the science behind enteric coated capsules and explore how they affect drug absorption.
Understanding Enteric Coated Capsules
Enteric coated capsules are designed to resist dissolution in the acidic environment of the stomach and instead release the drug in the more alkaline environment of the small intestine. This is achieved by applying a special coating to the capsule, which is insoluble at low pH levels but dissolves at higher pH levels. The coating is typically made from polymers such as cellulose acetate phthalate, hydroxypropyl methylcellulose phthalate, or methacrylic acid copolymers.
The main purpose of enteric coating is to protect the drug from the acidic environment of the stomach, which can degrade or inactivate certain drugs. By preventing the drug from being released in the stomach, enteric coated capsules ensure that the drug reaches the small intestine intact, where it can be absorbed more effectively. Additionally, enteric coating can also help to reduce gastrointestinal side effects by minimizing the contact of the drug with the stomach lining.
How Enteric Coated Capsules Affect Drug Absorption
The effect of enteric coated capsules on drug absorption can be attributed to several factors, including the site of drug release, the rate of drug dissolution, and the physiological conditions of the gastrointestinal tract.
Site of Drug Release
One of the key advantages of enteric coated capsules is that they allow for targeted drug delivery to the small intestine. The small intestine is the primary site of drug absorption in the body, as it has a large surface area and a rich blood supply. By releasing the drug in the small intestine, enteric coated capsules can enhance the absorption of drugs that are poorly absorbed in the stomach or are sensitive to gastric acid.
For example, some drugs, such as aspirin, can cause irritation and ulceration of the stomach lining when taken in their uncoated form. Enteric coated aspirin capsules can help to reduce these side effects by releasing the drug in the small intestine, where it can be absorbed without causing damage to the stomach.

Rate of Drug Dissolution
The rate of drug dissolution is another important factor that can affect drug absorption. Enteric coated capsules are designed to dissolve slowly in the small intestine, which can help to prolong the release of the drug and maintain a steady blood concentration. This can be particularly beneficial for drugs that have a short half-life or require a sustained release profile.
However, the slow dissolution rate of enteric coated capsules can also pose a challenge, as it may delay the onset of drug action. In some cases, the drug may not be released quickly enough to achieve the desired therapeutic effect, especially in emergency situations. Therefore, it is important to carefully consider the properties of the drug and the patient's needs when choosing an enteric coated capsule formulation.
Physiological Conditions of the Gastrointestinal Tract
The physiological conditions of the gastrointestinal tract, such as pH, motility, and transit time, can also influence drug absorption from enteric coated capsules. The pH of the small intestine is typically around 6-7.5, which is more alkaline than the stomach. This alkaline environment is necessary for the dissolution of the enteric coating and the release of the drug.
In addition, the motility and transit time of the gastrointestinal tract can affect the residence time of the capsule in the small intestine. If the capsule passes through the small intestine too quickly, there may not be enough time for the drug to dissolve and be absorbed. On the other hand, if the capsule stays in the small intestine for too long, there may be a risk of drug degradation or metabolism.
Factors to Consider When Using Enteric Coated Capsules
When using enteric coated capsules, it is important to consider several factors to ensure optimal drug absorption and therapeutic efficacy.
Patient Factors
The patient's age, gender, weight, and medical history can all affect drug absorption. For example, elderly patients may have a slower gastrointestinal transit time, which can increase the residence time of the capsule in the small intestine and potentially enhance drug absorption. On the other hand, patients with certain medical conditions, such as diabetes or inflammatory bowel disease, may have altered gastrointestinal physiology, which can affect the dissolution and absorption of enteric coated capsules.
Drug Factors
The properties of the drug, such as its solubility, stability, and permeability, can also influence drug absorption from enteric coated capsules. Drugs that are poorly soluble or have low permeability may require special formulation techniques or higher doses to achieve adequate absorption. In addition, some drugs may interact with the enteric coating or other components of the capsule, which can affect the release and absorption of the drug.
Food and Beverage Interactions
Food and beverages can also affect drug absorption from enteric coated capsules. Some foods, such as high-fat meals, can delay gastric emptying and increase the residence time of the capsule in the stomach, which can potentially reduce the effectiveness of the enteric coating. On the other hand, certain beverages, such as grapefruit juice, can inhibit the metabolism of some drugs and increase their bioavailability.
Our Enteric Coated Capsule Products
As a supplier of enteric coated capsules, we offer a wide range of high-quality products to meet the diverse needs of the pharmaceutical industry. Our enteric coated capsules are made from premium materials and are designed to provide excellent protection and controlled release of drugs.
We offer a variety of capsule sizes and shapes to accommodate different drug formulations and dosing requirements. Our Empty Gelatin Pill Capsule are made from natural gelatin and are suitable for a wide range of applications. We also offer Medical Gelatin Vacant Capsule that are specifically designed for pharmaceutical use and meet the highest quality standards.
In addition, we offer Size 0 Gelatin Empty Capsule, which are one of the most commonly used capsule sizes in the pharmaceutical industry. These capsules have a large capacity and are suitable for encapsulating a wide range of drugs, including powders, granules, and pellets.
Conclusion
Enteric coated capsules are a valuable tool in the pharmaceutical industry for improving drug absorption and reducing gastrointestinal side effects. By releasing the drug in the small intestine, enteric coated capsules can enhance the bioavailability of drugs that are poorly absorbed in the stomach or are sensitive to gastric acid. However, it is important to carefully consider the properties of the drug, the patient's needs, and the physiological conditions of the gastrointestinal tract when using enteric coated capsules.
As a leading supplier of enteric coated capsules, we are committed to providing high-quality products and excellent customer service. If you are interested in learning more about our enteric coated capsule products or would like to discuss your specific requirements, please feel free to contact us. We look forward to working with you to develop innovative drug delivery solutions that meet your needs.
References
- Lobenberg R, Amidon GL. Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards. Eur J Pharm Sci. 2000;11 Suppl 2:S3-12.
- Dressman JB, Reppas C. Physicochemical and physiological mechanisms for the effects of food on drug absorption: The role of lipids and pH. J Pharm Sci. 2000;89(8):935-955.
- Shah VP, Midha KK, Dighe S, et al. Biopharmaceutics classification system-based in vitro-in vivo correlations. Pharm Res. 2001;18(3):330-336.



